Paper41560433
Clinically Relevant Outcome Measures in Women With Adrenoleukodystrophy.
Yan C and 3 others. Ann Clin Transl Neurol, 2026. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Clinically Relevant Outcome Measures in Women With Adrenoleukodystrophy. Papers, record 41560433. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41560433
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adrenoleukodystrophy | Major topic |
| Outcome Assessment, Health Care | Major topic |
| Humans | |
| Female |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| K23 NS123258 | NINDS NIH HHS | United States | K23NS123258 | PubMed | NIH RePORTER |
| K23NS123258 | National Institute for Neurological Disorders and Stroke | K23NS123258 | PubMed | NIH RePORTER | |
| UM1TR004405 | NCATS NIH HHS | United States | UM1TR004405 | PubMed | NIH RePORTER |
References27
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 41030609 | Improving quality of life in rare diseases using disease-specific, multidisciplinary online interventions on the example of rare X-linked adrenoleukodystrophy: a randomized-controlled trial. | Ther Adv Neurol Disord | 2025 | https://conductscience.org/library/papers/41030609 | PubMed |
| 2 | 41508113 | Living with adrenoleukodystrophy: adult patient and caregiver perspectives. | Orphanet J Rare Dis | 2026 | https://conductscience.org/library/papers/41508113 | PubMed |
| 3 | 23300045 | The lived experience of Taiwanese mothers of a child diagnosed with adrenoleukodystrophy. | J Health Psychol | 2014 | https://conductscience.org/library/papers/23300045 | PubMed |
| 4 | 21312273 | Progression and prognostic factors of motor impairment, disability and quality of life in newly diagnosed Parkinson's disease. | Mov Disord | 2011 | https://conductscience.org/library/papers/21312273 | PubMed |
| 5 | 34796974 | Sensorimotor outcomes in adrenomyeloneuropathy show significant disease progression. | J Inherit Metab Dis | 2022 | https://conductscience.org/library/papers/34796974 | PubMed |
| 6 | 34943935 | Molecular Biomarkers for Adrenoleukodystrophy: An Unmet Need. | Cells | 2021 | https://conductscience.org/library/papers/34943935 | PubMed |
| 7 | 30732635 | Disease progression in women with X-linked adrenoleukodystrophy is slow. | Orphanet J Rare Dis | 2019 | https://conductscience.org/library/papers/30732635 | PubMed |
| 8 | 35245789 | Restless Legs Syndrome in X-linked adrenoleukodystrophy. | Sleep Med | 2022 | https://conductscience.org/library/papers/35245789 | PubMed |
| 9 | 38795020 | International validation of meaningfulness of postural sway and gait to assess myeloneuropathy in adults with adrenoleukodystrophy. | J Inherit Metab Dis | 2024 | https://conductscience.org/library/papers/38795020 | PubMed |
| 10 | 31719133 | Longitudinal diffusion MRI as surrogate outcome measure for myelopathy in adrenoleukodystrophy. | Neurology | 2019 | https://conductscience.org/library/papers/31719133 | PubMed |
| 11 | 39372123 | Practical Approach to Longitudinal Neurologic Care of Adults With X-Linked Adrenoleukodystrophy and Adrenomyeloneuropathy. | Neurol Genet | 2024 | https://conductscience.org/library/papers/39372123 | PubMed |
| 12 | 41079752 | Myelin-water imaging and multi-shell diffusion-weighted imaging in adults with adrenoleukodystrophy. | Brain Commun | 2025 | https://conductscience.org/library/papers/41079752 | PubMed |
| 13 | 29089175 | Comparison of C26:0-carnitine and C26:0-lysophosphatidylcholine as diagnostic markers in dried blood spots from newborns and patients with adrenoleukodystrophy. | Mol Genet Metab | 2017 | https://conductscience.org/library/papers/29089175 | PubMed |
| 14 | 1285753 | Validating the SF-36 health survey questionnaire: new outcome measure for primary care. | BMJ | 1992 | https://conductscience.org/library/papers/1285753 | PubMed |
| 15 | 39256476 | Lipidomic biomarkers in plasma correlate with disease severity in adrenoleukodystrophy. | Commun Med (Lond) | 2024 | https://conductscience.org/library/papers/39256476 | PubMed |
| 16 | 24410807 | Neurological impairment among heterozygote women for X-linked Adrenoleukodystrophy: a case control study on a clinical, neurophysiological and biochemical characteristics. | Orphanet J Rare Dis | 2014 | https://conductscience.org/library/papers/24410807 | PubMed |
| 17 | 39777696 | Progression of Spinal Cord Disease in Adult Men With Adrenoleukodystrophy. | J Inherit Metab Dis | 2025 | https://conductscience.org/library/papers/39777696 | PubMed |
| 18 | 36748403 | Self-reported quality of life in symptomatic and asymptomatic women with X-linked adrenoleukodystrophy. | Brain Behav | 2023 | https://conductscience.org/library/papers/36748403 | PubMed |
| 19 | 39584996 | Psychological Impact of Presymptomatic X-Linked ALD Diagnosis and Surveillance: A Small Qualitative Study of Patient and Parent Experiences. | Int J Neonatal Screen | 2024 | https://conductscience.org/library/papers/39584996 | PubMed |
| 20 | 22570090 | Severity score system for progressive myelopathy: development and validation of a new clinical scale. | Braz J Med Biol Res | 2012 | https://conductscience.org/library/papers/22570090 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 41951494 | Nervonic acid supplementation mitigates disease severity biomarkers in adrenoleukodystrophy. | Neurotherapeutics | 2026 | https://conductscience.org/library/papers/41951494 |
Source PubMed
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ABCD1 | 215 | PubTator's text mining | https://conductscience.org/library/genes/215 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41560433
GET https://conductscience.org/api/papers/v1/41560433/references?page=2